The FDA has approved the first rapid-acting biosimilar insulin product for glycemic control in people with diabetes. Merilog ...

Nance appealed and a panel of the U.S. Court of Appeals for the Eleventh Circuit concluded that since lethal injection is the ...

There appears to be limited evidence supporting the use of epidural steroid injections for certain types of chronic lower ...

Results of a placebo-controlled trial support prior observational findings that GLP-1 agonists can help reduce alcohol ...

Certain hormonal contraceptives are associated with a higher stroke and heart attack risk, finds a large study from Denmark ...

The future of Poland's aesthetic injectables market looks promising, with a projected increase in demand for hyaluronic acid ...

Multiple subcutaneous doses safe and well-tolerated >69% reduction in anti-VEGF intravitreal (IVT) treatment burden in study eyes >67% ...

A Phase 2 clinical trial testing obexelimab in adults with relapsing types of multiple sclerosis is now recruiting ...

Americans will soon have access to an infusion device that provides round-the-clock effective relief of Parkinson's disease.

The FDA has approved the first and only subcutaneous apomorphine infusion device, apomorphine hydrochloride injection (Onapgo ...

Enrollment of Part A completed ahead of schedule and exceeded enrollment target with 123 patients enrolledPart A 16-week proof-of-concept data ...

The trial aims to demonstrate improvement in pain and function with subcutaneous injections of iPPS compared with ...